SURVYR

MCK

McKesson Corporation
$960.56
−$6.46 (0.67%)Oct 28 close
Health CareS&P 500 CompareTechnicals
1M3M6M1Y2Y
-10%-1%+8%+18%+27%Oct 2025Oct 2026Apr 202652w high $1,030.2752w low $723.68
MCKSPY
Wall St. Highest PT $1,200.00 (+24.9%) Wall St. Avg PT $1,009.64 (+5.1%)
$724$852$980$1,108$1,236POC $822Hi $1,200Avg $1,010
Underwater Drawdown %Max DD -27.2%Current -6.8%
0.0%-27.2%
Relative Strength vs SPY+4.9% vs SPYOutperforming
+27%0%-27%
1W
−$54.94 (5.41%)
1M
+$104.27 (12.18%)
3M
+$72.94 (8.22%)
6M
+$139.71 (17.02%)
YTD
+$142.73 (17.45%)
1Y
+$159.13 (19.86%)

Chart

Loading live chart…

Ratings & dials

1m · 5m · 15m · 1h · 4h · 1D

Analyst & Morningstar ratings

Consensus · Targets · Morningstar
Wall Street analyst consensus
SellHoldStrong Buy
Buy
14 analysts · mean score 1.56
1 = Strong Buy · 5 = Sell
Wall Street consensus
Analyst price targets
Current price$960.56
Average target$1,009.64
+$49.08 (+5.1%) upsideaverage target vs current price
CurrentAverageMedian
Low$845.00
Median$1,009.64
High$1,200.00
12-month Wall Street target range

Third-party ratings, not SURVYR.'s views.

Key stats & company

Market value$116.7B
P/E (last 12 months)26.8
P/E (next 12 months, estimated)19.8
52-week range$723.68 – $1,030.27
Revenue growth (latest quarter vs a year ago)+7.7%
Dividend yield0.38%
Analyst consensusBuy (14)
Average analyst price target$1,009.64 (+5%)

What they do

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Healthcare · Medical Distribution
Valuation and fundamentals

Valuation & fundamentals

Loading the valuation from SEC filings…

For information only · Important disclosures

Grades vs sector

Momentum
38th percentile in sector
C-
12-1 return: +5.6%
Percentile within its GICS sector across the S&P 1500.
Growth
47th percentile in sector
C
Revenue growth (YoY): +7.7%
Percentile within its GICS sector across the S&P 1500.
Value
40th percentile in sector
C-
Forward E/P: 5.0% · EBITDA/EV: 5.6%
Percentile within its GICS sector across the S&P 1500.
Profitability
27th percentile in sector
D+
Profit margin: +1.1% · Return on equity: –
Percentile within its GICS sector across the S&P 1500.
Revisions
Not enough data yet
–
EPS estimate change, 30 days (current FY): –
30-day change in analysts' current-year EPS estimate; graded across covered stocks.

Systematic Models

Not held by any of our 7 live models right now.

Quality Growth
Outside this model's universe or screens
 Momentum Top 15
ranked 215 of 499 · 12-month momentum 14.9%
 Momentum Blend
Not in the current book
 New Highs Growth
Outside this model's universe or screens
 SURVYR. Barbell Momentum & T-Bill Shield
Outside this model's universe or screens
 SURVYR. Physical AI Grid & Power
Outside this model's universe or screens
 SURVYR. Long Book
Not in the current book

Earnings & events

MCK earningsNext report in 6 days
Next report · quarter Sep 2026
Wed Nov 4, 2026After the close
EPS consensus$10.75
Revenue consensus–
Last 4 quarters · EPS vs estimate
Aug 5, 2026$9.93est $9.54+4.1%Above estimates
May 7, 2026$11.69est $11.57+1.1%Above estimates
Feb 4, 2026$9.34est $9.27+0.7%In line with estimates
Nov 5, 2025$9.86est $9.05+8.9%Above estimates

In line = within 1% of the estimate.

Source: Yahoo Finance · report time: Nasdaq earnings calendar · refreshed 2026-10-27 18:05:45 ET
24-1125-0225-0525-0825-1126-0226-0526-080.0011.69
EstimateActual (beat)Actual (miss)

News & catalysts

More news
Notable ETF Outflow Detected - IYK, KO, MCK, CVS
Nasdaq · Oct 23
Daily Dividend Report: MCK,PB,HII,QCOM,ROL
Nasdaq · Oct 21
Strength Seen in Option Care (OPCH): Can Its 32.7% Jump Turn into More Strength?
Zacks · Oct 07
Insider trades
Fraga Francisco
EVP, CIO and CTO · 2026-10-15
Sell
$797.1K
Rutledge Napoleon B Jr
SVP, Controller & CAO · 2026-09-08
Sell
$99.0K
Lerman Bradley E
Director · 2026-08-10
Sell
$268.6K
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–
None
None · None
Sell
–

Stats refreshed 2026-10-27 18:05:45 ET from Yahoo Finance (yfinance). "–" means the data isn't available. Refresh now

Morning Brief (8 AM ET) & Market Close (4:30 PM ET), weekdays

Indexes, sectors, biggest movers, rates, top news, SURVYR. model changes and what's ahead. Free, two short emails each weekday.

Editions

Free. Not investment advice. Unsubscribe anytime.

SURVYR

Free to use. No card, no ads, no auto-renew.

Systematic research · Not investment advice · Hypothetical unless marked Live · Data: Yahoo Finance (15-min delayed), SEC EDGAR, House Clerk · Important disclosures · Contact desk@coteau.app

How it worksOur promiseTermsPrivacyData statusSend feedback
Coteau 0.9 · Oct 21, 2026